Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair
Launched by UNIVERSITY OF VALENCIA · Jan 16, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a new therapy called blood flow restriction therapy (BFRT) is when combined with standard exercises after surgery for a rotator cuff tear. The goal is to see if this combination helps improve shoulder muscle strength and mass more than just doing standard exercises alone. Participants in the study will be divided into two groups: one group will do only standard rehabilitation exercises, while the other will do those exercises with the added BFRT. The study will last for 12 weeks, and researchers will measure changes in shoulder strength, muscle mass, and other factors like pain and mobility at different points during the study.
To be eligible for this trial, participants should be between 40 and 65 years old and have a specific type of rotator cuff tear diagnosed through an MRI. They must also be able to read and understand Spanish. Certain conditions, like having a massive irreparable tear or a recent shoulder surgery, may exclude someone from participating. If you join the study, you will have regular check-ins over the 12 weeks to track your progress, and your overall health and quality of life will also be evaluated. This trial is not yet open for participants, but it aims to contribute valuable information on shoulder rehabilitation methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 40-65 years
- • Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging
- • Undergoing arthroscopic rotator cuff repair
- • Be able to read and understand Spanish
- Exclusion Criteria:
- • Massive irreparable rotator cuff tear
- • Concomitant fracture
- • Labral or nerve injury
- • Suspicious of developing a frozen shoulder
- • Revision surgery after rotator cuff repair
- • Previous corticosteroid injection (\< 6 months)
- • Recent surgery (\< 1 year) in the contralateral shoulder
- • History of deep venous thrombosis/pulmonary embolism, peripheral vascular disease, thrombophilia or clotting disorders
- • Severe or uncontrolled hypertension, or any comorbid condition that impedes participants to complete the intervention
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Temuco, Cautín, Chile
Temuco, , Chile
Patients applied
Trial Officials
Felipe Ponce-Fuentes, MSc
Principal Investigator
Universidad Mayor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported